Details of the Drug
General Information of Drug (ID: DMABLF7)
Drug Name |
PT-104
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
149488-13-1; Thiourea, N-(5-bromo-2-pyridinyl)-N'-(2-(2,6-difluorophenyl)ethyl)-; Thiourea, N-(5-bromo-2-pyridinyl)-N'-[2-(2,6-difluorophenyl)ethyl]-; PT-104; PETT Analog 57; PETT deriv. 21; AC1MHDJX; LY300046HCl Analog 1; CHEMBL88677; BDBM1890; SCHEMBL6905477; DTXSID00164313; ZINC3832005; 1-(2,6-Difluorophenethyl)-3-(5-bromo-2-pyridinyl)thiourea; 1-(5-bromo-2-pyridyl)-3-[2-(2,6-difluorophenyl)ethyl]thiourea; 3-(5-bromopyridin-2-yl)-1-[2-(2,6-difluorophenyl)ethyl]thiourea; N-(2-(2,6-Difluorophenyl)ethyl)-N -(2-(5-bromopyri
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 372.23 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||